People with Type 2 diabetes take Invokana, or the version with metformin—Invokamet, to regulate blood sugar levels. Treating Type 2 diabetes with medication, along with improved diet and exercise, is important; however, in the case of Invokana and Invokamet, the risks may outweigh the benefits.
Invokana is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is only FDA-approved to treat Type 2 diabetes, not Type 1.
Invokana is linked to diabetic ketoacidosis. This occurs when the body overproduces a blood acid, called a ketone. Ketoacidosis is a serious condition that can result in hospitalization.
Ketoacidosis symptoms include:
The US Food and Drug Administration issued a warning about diabetic ketoacidosis in May 2015. And adding to that warning, the FDA mandated that drug makers update warning labels to include information about ketoacidosis.
The FDA also required drug makers to begin postmarketing studies on ketoacidosis and patient health.
Another Invokana side effect is urinary tract infection that can cause kidney failure. People who used Invokana, and suffered kidney failure, ended up being hospitalized for their injuries.
Do you have an Invokana case?
We can help you determine if filing an Invokana lawsuit is the right decision. Our law firm offers free, no obligation case evaluations.
Contact Carey Danis & Lowe today. Call 1-800-721-2519, or complete our confidential online form.References: Invokana